Pharmacokinetics, efficacy, and safety of arsenic formulations in acute promyelocytic leukemia treatment.

Marvin-Peek J, Jen WY, Ravandi F

Open source

DOI
10.1080/17512433.2026.2652979
Published
2026 Apr
Container
Expert review of clinical pharmacology
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/17512433.2026.2652979,
  title = {Pharmacokinetics, efficacy, and safety of arsenic formulations in acute promyelocytic leukemia treatment.},
  author = {Marvin-Peek J and Jen WY and Ravandi F},
  year = {2026},
  journal = {Expert review of clinical pharmacology},
  doi = {10.1080/17512433.2026.2652979},
  url = {https://doi.org/10.1080/17512433.2026.2652979}
}

RIS

TY  - JOUR
TI  - Pharmacokinetics, efficacy, and safety of arsenic formulations in acute promyelocytic leukemia treatment.
AU  - Marvin-Peek J
AU  - Jen WY
AU  - Ravandi F
PY  - 2026
JO  - Expert review of clinical pharmacology
DO  - 10.1080/17512433.2026.2652979
UR  - https://doi.org/10.1080/17512433.2026.2652979
ER  - 

APA

J, M., WY, J., & F, R. (2026). Pharmacokinetics, efficacy, and safety of arsenic formulations in acute promyelocytic leukemia treatment.. Expert review of clinical pharmacology. https://doi.org/10.1080/17512433.2026.2652979

Source records